Joel R. Jung - 11 Jun 2024 Form 4 Insider Report for Renalytix plc (RNLX)

Role
Interim Chief Financial Office
Signature
/s/ Katie Kazem, Attorney-in-Fact
Issuer symbol
RNLX
Transactions as of
11 Jun 2024
Net transactions value
$0
Form type
4
Filing time
13 Jun 2024, 16:15:05 UTC
Previous filing
05 Jun 2024
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction RNLX Employee Stock Option (right to buy) Award $0 +60,000 $0.000000 60,000 11 Jun 2024 Ordinary Shares 60,000 $0.2067 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The exercise price is 0.1625 pounds sterling. The U.S. dollar equivalent of the exercise price is $0.2067 using the Bank of England rate as of June 10, 2024 (1.00 pound sterling = $1.272).
F2 One fourth (1/4th) of the shares subject to the option award shall vest on August 28, 2024, and the remaining shares shall vest in nine equal monthly installments thereafter, subject to the Reporting Person's continuous service.